WellSIM Biomedical Technologies, Inc. is a liquid biopsy biotechnology company developing and commercializing complete diagnostic solutions for non-invasive cancer testing through enrichment, isolation, and analytical interrogation of exosomes and extracellular vesicles from specimens such as plasma, urine, and saliva.